Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction.
about
Enigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of ArthritisThe Role of the Transcriptional Regulation of Stromal Cells in Chronic InflammationRole of T cell-glial cell interactions in creating and amplifying central nervous system inflammation and multiple sclerosis disease symptomsRole of suppressors of cytokine signaling 3 in bone inflammatory responsesInterleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritisThe inflammasome pyrin contributes to pertussis toxin-induced IL-1β synthesis, neutrophil intravascular crawling and autoimmune encephalomyelitisCritical and independent role for SOCS3 in either myeloid or T cells in resistance to Mycobacterium tuberculosisThe pathological and physiological roles of IL-6 amplifier activationEmerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasisImmune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic TargetsTriterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitisA systems model of phosphorylation for inflammatory signaling eventsSTATs in cancer inflammation and immunity: a leading role for STAT3IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury.Models of autoimmune demyelination in the central nervous system: on the way to translational medicine.The reverse-direction method links mass experimental data to human diseases.Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17/IL-6 axis.Administration of Mycobacterium leprae rHsp65 aggravates experimental autoimmune uveitis in mice.The synovio-entheseal complex in enthesoarthritis.High gene expression of inflammatory markers and IL-17A correlates with severity of injection site reactions of Atlantic salmon vaccinated with oil-adjuvanted vaccines.Deficient import of acetyl-CoA into the ER lumen causes neurodegeneration and propensity to infections, inflammation, and cancerGYF-21, an Epoxide 2-(2-Phenethyl)-Chromone Derivative, Suppresses Innate and Adaptive Immunity via Inhibiting STAT1/3 and NF-κB Signaling PathwaysAblation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis.Homeostatic defects in interleukin 18-deficient mice contribute to protection against the lethal effects of endotoxin.Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia.The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice.The signaling suppressor CIS controls proallergic T cell development and allergic airway inflammation.Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis.Th17 cells in autoimmune demyelinating disease.Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression.The glutaredoxin/S-glutathionylation axis regulates interleukin-17A-induced proinflammatory responses in lung epithelial cells in association with S-glutathionylation of nuclear factor κB family proteins.IL-6 as a druggable target in psoriasis: focus on pustular variants.Lipocalin 2 is a regulator of macrophage polarization and NF-κB/STAT3 pathway activationModulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling.Clinical associations of serum interleukin-17 in systemic lupus erythematosus.Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells.Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice.C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cellsIL-17 enhances tumor development in carcinogen-induced skin cancer.Development of a nanoparticulate formulation of retinoic acid that suppresses Th17 cells and upregulates regulatory T cells
P2860
Q26768254-49A2C48F-9769-4D37-B7E6-DCF2763BF57AQ26778930-9E75B422-8A91-425E-AC61-EDF505EDA0D3Q26795528-45EC8E45-1609-4FB7-AA1C-44668BE4B4B4Q26994711-7104F43B-766F-4F2E-85EF-F73929A1EA85Q27023777-2A5F66C6-7F5C-4C4D-81C5-DB60B5059FB4Q27325503-FA1CD5B6-15CB-424A-AB84-35BFDE7143A8Q27334479-CE25C0B3-AC31-4E0A-A78F-11DFE561942AQ27690908-6E8D3B22-69EB-4897-955E-4107D3075C52Q28069422-02CCEC5E-276F-4849-A9F6-4971DF27B4CCQ28079713-BBAC8DC5-F4FD-4B13-9816-81C062D5466AQ28394921-1CB2B5BE-95BD-41D5-B00C-3094984755C0Q28543980-B7883A54-40BC-4B32-85A9-399A63DB7A15Q29547203-2BAE60DB-2618-4956-BAEC-2081225B887EQ30437432-77BAA543-A7A5-481C-A317-F2ABD86E43F9Q30483471-682AC7FE-3F4E-43A5-B3A9-03C0B8868B2AQ30664511-3A151C4B-88AF-4162-8B39-72D1F84C7D8EQ30882988-8571366D-6658-4CEB-B57C-84BA8A2C8413Q30913978-14891995-D0B7-4286-9A2C-8998C6FEB2D7Q33360030-1B9345CA-503A-4325-B8DD-F654DF9097A4Q33589516-2EB25B21-D6AB-42C4-B5F9-79E73CE4E9BBQ33605735-AEAE6F8D-6102-4D56-9E57-DAD0F3270BCDQ33710758-6F578300-3F06-4601-817E-BD862782D10AQ33778033-21B05DE9-95F3-4B09-8226-ED9CD8175E54Q33802028-5F7ACD7D-4821-451F-B5DF-70EEF1C36D4FQ33810570-1B59F91F-F88B-4E87-90E7-DA8445A7D852Q33831012-785F4872-1D54-4FDE-94A1-4117D7296B20Q33855162-476C7F10-823C-4FB0-825D-11532A12BDAEQ33862239-32E219E6-7D63-42F6-A24B-B8733C571EAAQ33867796-52AB41E7-04D8-4A1B-A69F-7A84A4DEDB01Q33883569-28663FB4-F68B-4853-B215-4CEEB6DC09A8Q33954291-6153424C-F6EC-4539-945E-0F37FBE5AB20Q34003280-589561CB-6F1B-4AE2-B7D4-64259DEA24B7Q34265059-57240B7D-1581-430B-BEBF-1BF69AC0FC99Q34340648-A8CD7BF3-5EE8-482A-980E-59DC50882589Q34365880-CD3034A8-8EC5-4FD7-9DAC-629CA4DB9729Q34523687-EDFCAEF3-4721-4AD2-AD39-FD76D0EB0B0CQ34570874-C9F540EE-B6F3-48FE-BDA0-3C9D3CDE2459Q34579613-4F62B462-F9A3-4C94-815B-D85359FE785EQ34690808-6685C7EF-6FCD-43D5-875D-050A02E0CD9BQ34707563-234C6D8C-47AB-4458-B683-A0C432E7ABE1
P2860
Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Interleukin-17 promotes autoim ...... p via interleukin-6 induction.
@en
Interleukin-17 promotes autoim ...... p via interleukin-6 induction.
@nl
type
label
Interleukin-17 promotes autoim ...... p via interleukin-6 induction.
@en
Interleukin-17 promotes autoim ...... p via interleukin-6 induction.
@nl
prefLabel
Interleukin-17 promotes autoim ...... p via interleukin-6 induction.
@en
Interleukin-17 promotes autoim ...... p via interleukin-6 induction.
@nl
P2093
P1433
P1476
Interleukin-17 promotes autoim ...... p via interleukin-6 induction.
@en
P2093
Chika Kitabayashi
Masaaki Murakami
Mika Nishihara
Mineko Tsuruoka
Minoru Kanamoto
Toshio Hirano
Yuko Okuyama
P304
P356
10.1016/J.IMMUNI.2008.07.018
P407
P577
2008-10-09T00:00:00Z